EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieKohortenstudie

Oncological Outcomes for Primary Head and Neck Squamous Cell Carcinoma in the United Kingdom: Results From a National Cross‐Sectional Cohort Study

Frederick R Green, Andrew Williamson iD, Alison E Lim, Ying Ki Lee, Lucy Li, Christy Moen iD, Rishi Vasanthan, Olivia Wharf, Jeremy Wong iD, Vinidh Paleri, INTEGRATE Collaborators

Clinical Otolaryngology · 2026-07 · 51 (4) · 574-584

DOI: 10.1111/coa.70103 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Otolaryngology, online erschienen am 31.03.2026. Verfasst von Frederick R Green und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of ENT Head and Neck Surgery, University College London Hospital, London, UK. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate overall survival outcomes from primary head and neck squamous cell carcinoma (HNSCC) in the UK.

Design

A retrospective national observational cohort study with consecutive participants.

Setting

UK‐wide head and neck cancer centres.

Participants

All patients with HNSCC who received a definitive treatment decision between 01/09/2021 and 30/11/2021. Subgroup analysis of patients was stratified by head and neck subsites. Main Outcome Measures Two‐year overall (OS), disease‐free (DFS), disease‐specific (DSS), and local‐recurrence‐free‐survival (LRFS) from primary HNSCC.

Results

Data from 1488 patients was submitted by 50 centres, of which 1286 were primary HNSCC. Median age was 65.5 years (IQR 57–74), and 911 (71.0%) were male. The most common subsites were oropharynx (37.6%), oral cavity (28.3%), larynx (22.0%), and hypopharynx (6.8%). Treatment intent was curative in 79.9% of cases. Of treatment modalities, 529 (41.3%) underwent surgery, 874 (68.4%) underwent radiotherapy, and 391 (30.7%) underwent chemotherapy. Two‐year OS, DFS, DSS and LRFS were 79.7%, 72.2%, 84.8%, and 75.1%, respectively. Two‐year OS was 83.5%, 55.4%, 73.9% and 84.6% for laryngeal, hypopharyngeal, oral cavity and oropharyngeal subsites, respectively. On multivariate analysis, clinical T staging, age, ECOG performance status, and p16 status were independent prognostic factors for survival.

Conclusion

UK survival variations according to disease subsite reflect larger studies. Broader data over larger periods will reveal whether long‐term improvements in the diagnosis, biological understanding, and treatments of HNSCC have translated into improvements in UK survival outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansUnited KingdomMaleRetrospective StudiesAgedFemaleMiddle AgedCross-Sectional StudiesSurvival RateDisease-Free Survival

Stichwörter der Autor:innen

cohort studyhead and neck cancerhead and neck oncologyhead and neck squamous cell carcinomasurvival

Autor:innen und Institutionen

  • Department of ENT Head and Neck Surgery, University College London Hospital, London, UK.
  • Head and Neck Department, The Royal Marsden Hospital, London, UK.
  • The Institute for Cancer Research, London, UK.
  • Department of ENT Head and Neck Surgery, Queen Elizabeth University Hospital, Glasgow, UK.
  • Department of ENT Head and Neck Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Frimley Health NHS Foundation Trust, Frimley, UK.

ORCID-Profile: Andrew Williamson, Christy Moen, Jeremy Wong

Zitieren

APA

Green, F. R., Williamson, A., Lim, A. E., Lee, Y. K., Li, L., Moen, C., Vasanthan, R., Wharf, O., Wong, J., Paleri, V., & INTEGRATE Collaborators (2026). Oncological Outcomes for Primary Head and Neck Squamous Cell Carcinoma in the United Kingdom: Results From a National Cross‐Sectional Cohort Study. Clinical Otolaryngology, 51(4), 574-584. https://doi.org/10.1111/coa.70103

Vancouver

Green FR, Williamson A, Lim AE, Lee YK, Li L, Moen C, et al. Oncological Outcomes for Primary Head and Neck Squamous Cell Carcinoma in the United Kingdom: Results From a National Cross‐Sectional Cohort Study. Clinical Otolaryngology. 2026;51(4):574-584. doi:10.1111/coa.70103

BibTeX
@article{Green2026,
  author = {Green, Frederick R and Williamson, Andrew and Lim, Alison E and Lee, Ying Ki and Li, Lucy and Moen, Christy and Vasanthan, Rishi and Wharf, Olivia and Wong, Jeremy and Paleri, Vinidh and INTEGRATE Collaborators, INTEGRATE Collaborators},
  title = {Oncological Outcomes for Primary Head and Neck Squamous Cell Carcinoma in the United Kingdom: Results From a National Cross‐Sectional Cohort Study},
  journal = {Clinical Otolaryngology},
  year = {2026},
  volume = {51},
  number = {4},
  pages = {574--584},
  doi = {10.1111/coa.70103}
}
Kostenlos starten →